IO Biotech (IOBT) Institutional Ownership

$1.45
-0.01 (-0.69%)
(As of 11:12 AM ET)

Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)

Current
Institutional Ownership
Percentage
54.76%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$13.43M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$1.00M
Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IOBT Institutional Buying and Selling by Quarter

IO Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554%
2/13/2024Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529%
2/13/2024Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920%
11/15/2023Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260%
11/14/2023Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998%
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312%
11/8/2023 Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371%
7/25/2023 Summit Trail Advisors LLC43,744$86K0.0%N/A0.152%
2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911%
11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142%
11/2/2022Victory Capital Management Inc.43,741$119K0.0%N/A0.152%
2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888%
2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286%
2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335%
2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376%
(Data available from 1/1/2016 forward)

IOBT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOBT shares?

During the previous two years, 9 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Armistice Capital LLC ($3.62M), Stonepine Capital Management LLC ($3.13M), RA Capital Management L.P. ($2.59M), Pivotal bioVenture Partners Investment Advisor LLC ($1.22M), and Victory Capital Management Inc. ($119K).Learn more on IOBT's institutional investors.

What percentage of IO Biotech stock is owned by institutional investors?

54.76% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings.

Which institutional investors have been buying IO Biotech stock?

The following institutional investors have purchased IO Biotech stock in the last 24 months: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Summit Trail Advisors LLC ($43.74K), and Victory Capital Management Inc. ($43.74K).

How much institutional buying is happening at IO Biotech?

Institutional investors have bought a total of 9,261,384 shares in the last 24 months. This purchase volume represents approximately $13.66M in transactions.

Which IO Biotech major shareholders have been selling company stock?

The following institutional investors have sold IO Biotech stock in the last 24 months: RA Capital Management L.P. ($730.50K), Stonepine Capital Management LLC ($309.27K), and Armistice Capital LLC ($224K).

How much institutional selling is happening at IO Biotech?

Institutional investors have sold a total of 1,263,766 shares in the last 24 months. This volume of shares sold represents approximately $2.68M in transactions.


This page (NASDAQ:IOBT) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners